Status:
COMPLETED
Assessment of Compliance With Antihypertensive Telmisartan Therapy
Lead Sponsor:
Bayer
Collaborating Sponsors:
Bang & Olufsen Medicom
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients ...
Eligibility Criteria
Inclusion
- Age over 18
- Untreated or ineffectively treated arterial hypertension
Exclusion
- Cholestatic disorders and severe hepatic failure
- Allergy to Telmisartan
- Pregnancy and lactation period
- Unwillingness to participate in the study
- Inability to use the drug reminder device
- Unwillingness to use the drug reminder device
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
3400 Patients enrolled
Trial Details
Trial ID
NCT00470886
Start Date
April 1 2007
End Date
January 1 2010
Last Update
November 16 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Poland
2
Many Locations, Slovakia